NeoPharm CO., LTD. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	268,560	287,330	180,766	202,163	150,156	193,952
Market Cap Growth	35.30%	58.95%	-10.58%	34.63%	-22.58%	-13.13%
Enterprise Value	128,737	154,628	66,098	78,166	45,545	97,728
Last Close Price	17170.00	18370.00	11384.69	11811.25	8517.25	10615.43
PE Ratio	9.65	10.33	7.84	8.71	8.82	10.95
Forward PE	8.39	8.05	8.05	8.05	8.05	10.43
PS Ratio	2.03	2.17	1.52	2.08	1.77	2.21
PB Ratio	1.37	1.47	1.02	1.26	1.06	1.49
P/TBV Ratio	1.39	1.48	1.03	1.28	1.07	1.51
P/FCF Ratio	9.86	10.55	11.42	59.27	8.48	9.08
P/OCF Ratio	9.45	10.11	9.70	8.69	8.27	8.95
PEG Ratio	-	5.64	5.64	5.64	5.64	5.64
EV/Sales Ratio	0.97	1.17	0.56	0.81	0.54	1.11
EV/EBITDA Ratio	4.03	4.84	2.38	2.90	1.98	4.08
EV/EBIT Ratio	4.47	5.37	2.68	3.09	2.12	4.36
EV/FCF Ratio	4.73	5.68	4.18	22.92	2.57	4.58
Debt / Equity Ratio	0.01	0.01	0.00	0.01	0.00	0.00
Debt / EBITDA Ratio	0.06	0.06	0.02	0.04	0.02	0.02
Debt / FCF Ratio	0.07	0.07	0.04	0.31	0.02	0.03
Net Debt / Equity Ratio	-0.72	-0.72	-0.71	-0.69	-0.79	-0.80
Net Debt / EBITDA Ratio	-4.38	-4.38	-4.53	-4.11	-4.90	-4.37
Net Debt / FCF Ratio	-5.14	-5.14	-7.95	-32.52	-6.39	-4.89
Asset Turnover	0.64	0.64	0.64	0.58	0.57	0.64
Inventory Turnover	3.24	3.24	3.93	3.35	3.19	3.18
Quick Ratio	7.32	7.32	9.21	7.22	9.22	8.74
Current Ratio	8.40	8.40	10.12	7.94	9.99	9.39
Return on Equity (ROE)	14.95%	14.95%	13.69%	15.36%	12.50%	14.28%
Return on Assets (ROA)	8.77%	8.77%	8.33%	9.50%	8.97%	10.14%
Return on Invested Capital (ROIC)	44.62%	46.59%	37.61%	51.12%	56.96%	64.53%
Return on Capital Employed (ROCE)	14.60%	14.60%	13.90%	15.80%	15.10%	17.20%
Earnings Yield	10.36%	9.68%	12.76%	11.48%	11.34%	9.13%
FCF Yield	10.14%	9.47%	8.76%	1.69%	11.79%	11.01%
Dividend Yield	4.37%	4.08%	5.27%	3.17%	4.11%	3.30%
Payout Ratio	33.73%	33.73%	25.43%	23.58%	32.15%	28.70%
Buyback Yield / Dilution	-	-	-	-	-	0.95%
Total Shareholder Return	4.34%	4.08%	5.27%	3.17%	4.11%	4.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.